Andrew J. Gawron

About

Dr. Andrew Gawron is a gastroenterologist at University of Utah Health. His expertise includes the diagnosis and management of gastrointestinal conditions, with a focus on colorectal health. In the context of recent research, he discusses the increasing incidence of colorectal cancer among younger adults, emphasizing that while the disease remains rare in this population, there has been a notable rise in new cases, particularly in individuals under 50. Dr. Gawron highlights the importance of awareness of symptoms such as changes in bowel habits, bleeding, unexplained weight loss, and other warning signs, advocating for proactive patient advocacy and timely medical evaluation. He underscores the significance of understanding family history and personal risk factors, noting that most colorectal cancers in young people are sporadic and not linked to family history. Dr. Gawron emphasizes lifestyle choices, including diet, exercise, and avoiding smoking and processed meats, as crucial for prevention. His approach advocates for early detection through symptom awareness and lifestyle modifications, aiming to improve outcomes and reduce the burden of colorectal cancer in younger populations.

Research topics

• Medicine
• Internal medicine
• Surgery
• Demography
• Anesthesia
• Oncology
• Radiology
• Emergency medicine

Selected publications

• Risk Factors for Early-Onset Colorectal Cancer

  Gastroenterology · 2020 · 218 citations

  DOI

• Adenoma Detection Rate (ADR) Irrespective of Indication Is Comparable to Screening ADR: Implications for Quality Monitoring

  Clinical Gastroenterology and Hepatology · 2021 · 47 citations

  DOI

• Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial

  JAMA Network Open · 2023 · 29 citations

  Importance: The Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) randomized clinical trial sought to recruit 50 000 adults into a study comparing colorectal cancer (CRC) mortality outcomes after randomization to either an annual fecal immunochemical test (FIT) or colonoscopy. Objective: To (1) describe study participant characteristics and (2) examine who declined participation because of a preference for colonoscopy or stool testing (ie, fecal…

  PublisherOA PDFDOI

• Safety of endoscopist-directed nurse-administered balanced propofol sedation in patients with severe systemic disease (ASA class III)

  Gastrointestinal Endoscopy · 2020 · 20 citations

  Senior authorCorresponding
  DOI

• Disparities in Colorectal Cancer Screening Among Asian American Populations and Strategies to Address These Disparities

  Gastroenterology · 2024-03-21 · 5 citations

  articleOpen access
  PublisherOA PDFDOI

Frequent coauthors

• Tonya Kaltenbach

  174 shared

• Samir Gupta

  Moores Cancer Center

  115 shared

• Ranier Bustamante

  VA San Diego Healthcare System

  89 shared

• Ashley Earles

  88 shared

• Marı́a Elena Martı́nez

  85 shared

• Jason A. Dominitz

  United States Department of Veterans Affairs

  82 shared

• Karen Messer

  Concordia University

  75 shared

• Deborah A. Fisher

  Eli Lilly (United States)

  74 shared

Labs

• University of Utah Health - Andrew J. Gawron LabPI

Education

• M.D.

  Northwestern University

• Other

  Northwestern University

• Other

  Northwestern University

Similar researchers at University of Utah

• John M. Inadomih-78
• John Erikson Yaph-56
• John F. Valentineh-55